Amortization of Intangible Assets in USD of X4 Pharmaceuticals, Inc from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2022 to 2024.
  • X4 Pharmaceuticals, Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $200K.
  • X4 Pharmaceuticals, Inc annual Amortization of Intangible Assets for 2024 was $500K.
  • X4 Pharmaceuticals, Inc annual Amortization of Intangible Assets for 2023 was $0.000.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, Annual (USD)

X4 Pharmaceuticals, Inc Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $200K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $100K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08

X4 Pharmaceuticals, Inc Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $500K +$500K Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.